Search alternatives:
largest decrease » largest decreases (Expand Search), larger decrease (Expand Search), marked decrease (Expand Search)
large decrease » marked decrease (Expand Search), large increases (Expand Search), large degree (Expand Search)
c largest » _ largest (Expand Search), c large (Expand Search)
152 cases » 19 cases (Expand Search), 16 cases (Expand Search), 1 cases (Expand Search)
ic cases » 19 cases (Expand Search), _ cases (Expand Search), 3 cases (Expand Search)
b large » _ large (Expand Search), a large (Expand Search), i large (Expand Search)
largest decrease » largest decreases (Expand Search), larger decrease (Expand Search), marked decrease (Expand Search)
large decrease » marked decrease (Expand Search), large increases (Expand Search), large degree (Expand Search)
c largest » _ largest (Expand Search), c large (Expand Search)
152 cases » 19 cases (Expand Search), 16 cases (Expand Search), 1 cases (Expand Search)
ic cases » 19 cases (Expand Search), _ cases (Expand Search), 3 cases (Expand Search)
b large » _ large (Expand Search), a large (Expand Search), i large (Expand Search)
-
161
-
162
-
163
-
164
-
165
-
166
-
167
-
168
-
169
-
170
-
171
-
172
Table 1_Association of dynamic changes in metabolic syndrome components with clinical outcomes in diffuse large B-cell lymphoma.docx
Published 2025“…Introduction<p>Diffuse Large B-Cell Lymphoma (DLBCL) is the most common subtype of Non-Hodgkin Lymphoma (NHL), with 20-40% of patients experiencing poor outcomes despite advancements in treatment. …”
-
173
-
174
-
175
-
176
-
177
-
178
-
179
-
180
Table_3_Matrix Metallopeptidase 14: A Candidate Prognostic Biomarker for Diffuse Large B-Cell Lymphoma.XLS
Published 2020“…However, the correlation between MMP14 expression, prognosis, and immune cell infiltration in diffuse large B-cell lymphoma (DLBCL) remains unclear.</p>Methods<p>We investigated the influence of MMP14 on clinical prognosis using data obtained from three Gene Expression Omnibus (GEO) database sets (GSE98588, GSE10846, and GSE4475). …”